| Literature DB >> 31838651 |
Eva Warensjö Lemming1, Andrea Montano Montes2, Jessica Schmidt3, Benedikt Cramer3, Hans-Ulrich Humpf3, Lotta Moraeus4, Monica Olsen4.
Abstract
The exposure to mycotoxins of Swedish adolescents is currently unknown. The aim of the present study was to investigate the exposure to mycotoxins and their association with food intake, and background characteristics in adolescents of a national dietary survey. About 3000 school students (1000 from the 5th, 8th and 11th school years) were recruited for the survey. The participants completed Web-based questionnaires on food propensity, sociodemography and health, and a Web-based dietary recall. Spot urine and blood samples were collected from 1105 of the participants for mycotoxin biomarker analysis. Mycotoxins were analysed with multibiomarker methods in urine (HPLC-MS/MS) and serum (HPLC-MS/MS). Of the 35 different analytes in urine, the frequency of positive samples were the following: deoxynivalenol (DON, 4.8%), DON-15-β-D-O-glucuronide (DON-15GlcA, 9.1%), dihydro-citrinone (DH-CIT, 0.5%), HT-2-glucuronide (HT-2-3-GlcA, 0.1%) and ochratoxin A (OTA, 0.1%). Of the 27 different analytes in serum, OTA was detected in all samples, while 2'R-ochratoxin A (2'R-OTA) was found in 8.3% and enniatin B (EnB) in 99.2% of the samples. Exposure assessment calculations were performed on OTA from the serum concentration and on DON equivalents (DON eqv) from the urine concentration. All probable daily intake (PDI) estimates were below tolerable daily intakes, except for 1.6% of the participants for DON. The maximum PDI was 4.3 μg DON eqv/kg body weight and day. Consumption of cereal grain commodities was associated with levels of DON, EnB or OTA in biofluids. Serum OTA was also associated with intakes of raisins and coffee. Furthermore, coffee consumption correlated well with 2'R-OTA concentration in serum. In conclusion, exposure to mycotoxins in Swedish adolescents is common, but fortunately, high exposure was rare.Entities:
Keywords: 2’R-ochratoxin A; Deoxynivalenol; Dietary recall; Enniatin B; Ochratoxin A
Mesh:
Substances:
Year: 2019 PMID: 31838651 PMCID: PMC7182616 DOI: 10.1007/s12550-019-00381-9
Source DB: PubMed Journal: Mycotoxin Res ISSN: 0178-7888 Impact factor: 3.833
Background characteristics of the participants in the Riksmaten adolescents 2016–2017 study, divided by school year
| School year | 5 | 8 | 11 |
|---|---|---|---|
| 331 | 411 | 354 | |
| Proportion of girls (%) | 50 | 56 | 62 |
| Weight (kg) | 44 ± 10 | 59 ± 11 | 68 ± 13 |
| Age (years) | 11.6 ± 0.4 | 14.5 ± 0.4 | 17.8 ± 0.7 |
| Energy intake (kJ) | 8200 ± 1700 | 9600 ± 2600 | 9330 ± 2400 |
| Breads and cereals day 1 (g) | 136 (65; 237) | 199 (114; 298) | 175 (76; 309) |
| Breads day 1 (g) | 48 (6; 95) | 65 (0; 114) | 54 (0; 114) |
| Whole grain, day 1 (g) | 16 (3; 43) | 24 (6; 53) | 19 (5; 53) |
| Fibre, day 1 (g) | 16 (12; 22) | 19 (13; 26) | 18 (12; 25) |
| Raisins1(g) | 0.20 ± 1.2 | 0.80 ± 5.0 | 0.30 ± 2.0 |
| Coffee1 (g) | 1.0 ± 14 | 10 ± 50 | 55 ± 148 |
Values are given in mean ± standard deviation and median and 25th and 75th percentiles
1Long-term intake, mean of the consumption on days 1, 2 and 3
Occurrence and concentration of ochratoxin A (OTA), 2’R-ochratoxin A (2’R-OTA) and enniatin B (EnB) in positive serum samples divided by school year and sex
| School year | Sex | OTA | 2’R-OTA | EnB | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % > LOQ | Mean1 (ng/ml) | Median (ng/ml) | Max (ng/ml) | % > LOQ | Mean (ng/ml) | Median (ng/ml) | Max (ng/ml) | % > LOQ | Mean (ng/ml) | Median (ng/ml) | Max (ng/ml) | |||
| 5 | Female | 165 | 60.6 | 0.059 ± 0.039 | 0.056 | 0.223 | 0 | < ½ LOQ | < ½ LOQ | < LOQ | 80.6 | 0.014 ± 0.013 | 0.010 | 0.093 |
| Male | 166 | 69.3 | 0.059 ± 0.030 | 0.059 | 0.220 | 0 | < ½ LOQ | < ½ LOQ | < LOQ | 89.7 | 0.015 ± 0.013 | 0.012 | 0.113 | |
| 8 | Female | 230 | 57.4 | 0.053 ± 0.030 | 0.053 | 0.178 | 0 | < ½ LOQ | < ½ LOQ | < LOQ | 80.0 | 0.013 ± 0.012 | 0.011 | 0.098 |
| Male | 180 | 56.7 | 0.055 ± 0.034 | 0.056 | 0.237 | 1.1 | 0.036 ± 0.025 | < ½ LOQ | 0.098 | 61.7 | 0.013 ± 0.012 | 0.010 | 0.096 | |
| 11 | Female | 219 | 58.0 | 0.053 ± 0.049 | 0.052 | 0.658 | 1.4 | 0.028 ± 0.012 | < ½ LOQ | 0.076 | 87.7 | 0.013 ± 0.009 | 0.010 | 0.060 |
| Male | 136 | 49.3 | 0.050 ± 0.049 | 0.025 | 0.517 | 5.1 | 0.037 ± 0.027 | < ½ LOQ | 0.136 | 56.2 | 0.018 ± 0.013 | 0.014 | 0.080 | |
| All | 1096 | 58.7 | 0.055 ± 0.039 | 0.054 | 0.658 | 1.1 | 0.032 ± 0.020 | < ½ LOQ | 0.136 | 84.1 | 0.014 ± 0.012 | 0.011 | 0.113 | |
Values between LOD and LOQ were replaced with ½ LOQ OTA LOQ, 0.05 ng/ml; LOD, 0.014 ng/ml; 2’R-OTA LOQ, 0.05 ng/ml; LOD, 0.014 ng/ml; EnB LOQ, 0.005 ng/ml; LOD, 0.0013 ng/ml
n number of participants, LOQ limit of quantitation
1Mean is calculated in positive samples, excluding values < LOD (limit of detection)
Fig. 1Correlation of total DON (ng/ml) in 10 urine samples collected in Riksmaten adults 2010–2011 (Wallin et al. 2013) measured by two different methods. The method used in Wallin et al. (2013) was immunoaffinity cleanup method (x-axis) and the second, the “dilute and shoot (DaS)” approach, the method used in the present study (y-axis)
Concentration of deoxynivalenol (DON) and DON-15-β-D-O-glucuronide (DON-15GlcA) in positive urine samples, unadjusted for density, divided by school year and sex
| School year | Sex | Number | DON (ng/ml) | DON-15GlcA (ng/ml) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| % > LOQ1 | Mean2 | Median | Max | % > LOQ1 | Mean2 | Median | Max | |||
| 5 | Female | 165 | 6.7 | 8.4 ± 8.8 | 18.7 | 27.6 | 10.9 | 15.0 ± 8.5 | 12.4 | 38.3 |
| Male | 166 | 1.8 | 27.1 ± 38.4 | 55.4 | 102.3 | 13.3 | 16.3 ± 14.3 | 12.1 | 58.7 | |
| 8 | Female | 232 | 3.9 | 23.1 ± 23.0 | 32.7 | 82.4 | 6.0 | 19.8 ± 13.5 | 14.8 | 45.4 |
| Male | 179 | 6.2 | 13.0 ± 18.2 | 46.6 | 46.6 | 7.9 | 21.5 ± 15.3 | 19.2 | 59.7 | |
| 11 | Female | 219 | 4.6 | 16.8 ± 18.7 | 18.6 | 65.1 | 6.4 | 19.6 ± 10.0 | 16.3 | 40.6 |
| Male | 135 | 3.0 | 10.5 ± 15.4 | 33.6 | 33.6 | 11.1 | 14.9 ± 6.7 | 13.3 | 29.4 | |
| All | 1096 | 4.8 | 16.0 ± 21.7 | 26.2 | 102.3 | 9.0 | 17.5 ± 11.8 | 13.6 | 59.7 | |
Values between LOD and LOQ were replaced with ½ LOQ LOD for DON, 1.7 ng/ml, and for DON-15GlcA, 1.0 ng/ml
1LOQ (limit of quantitation) LOQ for DON, 5.6 ng/ml, and for DON-15GlcA, 3.3 ng/ml
2Mean is calculated in positive samples, excluding values < LOD (limit of detection)
The direction (positive (+) or negative (−)) of the associations and p values from the crude regression analysis between foods, nutrients and mycotoxins detected in urine and serum
| DON equivalents in urine | Enniatin B in serum | OTA in serum | |||||
|---|---|---|---|---|---|---|---|
| n | |||||||
| Breads and cereal products, day 1 | 1096 | * | 0.002 | – | 0.46 | ||
| Breads, day 1 | 1096 | * | + | < 0.001 | + | 0.18 | |
| Oats, day 1 | 491 | + | 0.01 | + | 0.01 | + | 0.07 |
| Whole grain rice, day 1 | 297 | + | 0.11 | + | 0.003 | – | 0.66 |
| Rice, day 1 | 383 | + | 0.06 | + | < 0.001 | – | 0.60 |
| Rye, day 1 | 644 | + | 0.08 | + | 0.023 | + | 0.33 |
| Whole grain wheat, day 1 | 414 | – | 0.27 | + | < 0.001 | + | 0.33 |
| Sifted wheat, day 1 | 1077 | – | 0.18 | + | < 0.001 | – | 0.64 |
| Wholegrain, day 1 | 972 | + | 0.004 | + | 0.17 | – | 0.13 |
| Wholegrain, usual | 1096 | + | 0.001 | + | 0.03 | – | 0.05 |
| Dietary fibre, day 1 | 1096 | + | 0.009 | + | < 0.001 | + | 0.03 |
| Dietary fibre, usual | 1096 | + | 0.004 | + | < 0.001 | + | 0.13 |
Usual refers to the long-term intake based on intake from all 3 days of registration. The regression analysis was a median regression model, using bootstrapping over 1000 replications to produce robust estimates
n number of consumers, DON deoxinivalenol, OTA ochratoxin A
Probable daily intakes (PDI, ng/kg bw) for total DON equivalents (DON+DON-15GlcA) calculated from urine samples adjusted for density or creatinine
| School year | Sex | PDI DON eqv. (ng/kg bw) density adjusted | PDI DON eqv (ng/kg bw) creatinine adjusted | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LB mean ± SD (median) | MB mean ± SD (median) | UB mean ± SD (median) | Maximum | LB mean ± SD (median) | MB mean ± SD (median) | UB mean ± SD (median) | Maximum | ||||
| 5 | Female | 165 | 49 ± 160 (0) | 91 ± 160 (40) | 130 ± 170 (79) | 1050 | 157 | 43 ± 180 (0) | 74 ± 180 (26) | 110 ± 180 (53) | 1750 |
| Male | 166 | 92 ± 490 (0) | 131 ± 480 (38) | 170 ± 480 (76) | 4290 | 160 | 41 ± 200 (0) | 76 ± 200 (29) | 110 ± 210 (58) | 2220 | |
| 8 | Female | 232 | 44 ± 250 (0) | 79 ± 250 (29) | 1140 ± 240 (58) | 1970 | 224 | 35 ± 170 (0) | 67 ± 170 (27) | 100 ± 180 (55) | 1870 |
| Male | 179 | 38 ± 190 (0) | 68 ± 190 (26) | 99 ± 190 (51) | 1600 | 170 | 40 ± 180 (0) | 74 ± 180 (28) | 110 ± 190 (56) | 1590 | |
| 11 | Female | 219 | 59 ± 300 (0) | 114 ± 300 (42) | 170 ± 300 (85) | 3340 | 210 | 42 ± 290 (0) | 73 ± 290 (26) | 100 ± 290 (53) | 3009 |
| Male | 135 | 33 ± 120 (0) | 75 ± 120 (36) | 120 ± 130 (71) | 1040 | 123 | 94 ± 370 (0) | 124 ± 360 (29) | 160 ± 360 (57) | 2570 | |
| Total | All | 1096 | 53 ± 280 (0) | 94 ± 280 (35) | 130 ± 280 (69) | 4290 | 1044 | 46 ± 240 (0) | 78 ± 240 (28) | 110 ± 240 (55) | 3009 |
eqv equivalents, n number of participants, LB lower bound, MB middle bound, UB upper bound
1Samples with creatinine levels < 0.3 or > 3.0 mg/ml are deleted according to Cocker et al. (2011)
Probable daily intake (PDI) estimation of lower bound, middle bound and upper bound means based on OTA concentration in serum, calculated using two different models
| OTA PDI (ng/kg bw/day) | ||||
|---|---|---|---|---|
| LB | MB | UB | Max | |
| Model 1 ( | 0.09 | 0.11 | 0.13 | 1.23 |
| Model 2 ( | 0.20 | 0.25 | 0.29 | 2.97 |
OTA ochratoxin A, LB lower bound, MB middle bound, UB upper bound, Max maximum intake, Cp plasma concentration, k mean daily intake
1Based on renal clearance